Atlas Trials

Intravitreal Diclofenac Versus Intravitreal Ranibizumab for the Treatment of Diabetic Macular Edema.

Clinical trial NCT03458923 · UNKNOWN

Trial details

NCT number
NCT03458923
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Macular Edema
Start date
2015-01-01
Primary completion
2018-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.